Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy

Radiotherapy and Oncology

Volumn 50, Issue 2, 1999, Pages 225-234

  Zelefsky, Michael J ^a   Crean, Diane ^b   Mageras, Gig S ^b   Lyass, Olga ^a   Happersett, Laura ^b   Clifton Ling, C ^b   Leibel, Steven A ^a   Fuks, Zvi ^a   Bull, Sarah ^b   Kooy, Hanne M ^c   Van Herk, Marcel ^d   Kutcher, Gerald J ^e  

^a Department of Radiation Oncology 1275 York Avenue ^*  (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

CT scans; Prostate motion; Systematic errors

Indexed keywords

ARTICLE; BLADDER CAPACITY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; HUMAN; HUMAN CELL; HUMAN TISSUE; PATIENT POSITIONING; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; TUMOR LOCALIZATION;

EID: 0032917307     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00011-0     Document Type: Article

References (27)

1. Balter J.M., Sandler H.M., Lam K., Bree R.L., Lichter A.S., Ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;113-118.
2. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;451-458.
3. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-220.
4. Forman J.D., Duclos M., Shamsa F., Porter A.T., Orton C. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;655-662.
5. Goitein M. Nonstandard deviations. Med. Phys. 10:1983;709-711.
6. Hanks G.E., Lee W.R., Hanlon A.L., et al. Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/ml. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;862 - 868.
7. Hanley J., Lumley M.A., Mageras G.S., et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;435-444.
8. ICRU Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements, Bethesda, MD, 1993.
9. Lebesque J.V., Bruce A.M., Kroes A.P.G., Touw A., Shouman T., van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer, Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1109-1119.
10. Lee W.R., Hanks G.E., Hanlon A., Schultheiss T.E., Hunt M.A. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;251-257.
11. Leibel S.A., Zelefsky M.J., Kutcher G.J., et al. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Semin. Oncol. 21:1994;580-597.
12. Mageras G.S., Kutcher G.J., Leibel S.A., Zelefsky M.J., Melian E., Mohan R., Fuks Z. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;333-342.
13. Mantel N. Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemo. Rep. 50:1966;163-170.
14. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;73-81.
15. Pollack A., Zagars G.K. External beam radiotherapy dose-response of prostate cancer. Int. Radiat. Oncol. Biol. Phys. 39:1997;1011-1018.
16. Roach M. III, Meehan S., Kroll S., et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J. Urol. 156:1996;1719-1723.
17. Roach M. III, Picket B., Rosenthal S.A., Verhey L., Phillips T.L. Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 28:1996;267-275.
18. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder and rectum during a course of external beam radiation therapy, Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1321-1329.
19. Rudat V., Schraube P., Oetzel D., Zierhut D., Flentje M., Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;1027-1034.
20. Schild S.E., Casale H.E., Bellefontaine L.P. Movements of the prostate due to rectal and bladder distention: implications for radiotherapy. Med. Dosim. 18:1993;13-15.
21. Ten Haken R.K., Forman J.D., Heimberger D.K., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;1317-1324.
22. van Herk M., Bruce A., Kroes A.P.G., Shouman T., Touw A., Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional (3D) image registration. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1311-1320.
23. van Herk M., Kooy H.M. Automatic three-dimensional correlation of CT-CT. CT-MRI and CT-SPECT using chamfer matching, Med. Phys. 21:1994;1163-1173.
24. Zelefsky M.J., Happersett L., Leibel S.A., et al. The effect of treatment positioning or normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;13-19.
25. Zelefsky M.J., Leibel S.A., Kutcher G.J., Kelson S., Ling C.C., Fuks Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J. Sci. Am. 1:1995;142-150.
26. Zelefsky M.J., Leibel S.A., Kutcher G.J., Fuks Z. Three -dimensional conformal radiotherapy and dose escalation: where do we stand? Semin. Rad. Oncol. 8:1998;107-114.
27. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;491-500.